$XBI $123.44
Pipeline Updates
$FBIO Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition. source
$AZN Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis. source
$CCXI ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis. source
$RLAY Relay Therapeutics Announces Interim Clinical Data that Support RLY-4008 as a Highly Selective FGFR2 Inhibitor. source
Financial & Business Updates
$LQDA Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent. source
$AGRX Priced offering at $0.85 per share. source
$XERS Acquisition completed with Strongbridge. source
$PCRX PACIRA BIOSCIENCES TO HOST INVESTOR DAY ON OCTOBER 15TH, 2021 IN TAMPA, FL. source
$HGEN Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program in Europe. source
$CDAK Sarepta terminated Research License and Option Agreement. source
Posted by DV
Comments